Cockroach Findings in Food Facilities: What FDA Warning Letters Reveal

Of all the pest findings that appear in FDA warning letters, cockroach findings generate the most immediate regulatory concern. Unlike rodent activity — which can be explained by exterior pressure and structural gaps — cockroach infestations in food facilities typically indicate conditions that have been developing for weeks or months undetected. That gap between onset and detection is exactly what FDA inspectors examine.

Understanding why cockroach findings escalate so quickly to formal enforcement action requires understanding what FDA is actually evaluating — and it is not the cockroach itself.

What FDA Warning Letters Reveal About Cockroach Findings

Across documented FDA warning letters involving cockroach activity in food facilities, three patterns appear consistently:

1. The Detection Gap

In the majority of cockroach-related enforcement cases, FDA inspectors find live or dead cockroaches in areas that are covered by the facility's pest monitoring program. The devices are present. The service reports document inspection of those devices. Yet the cockroach population went undetected long enough to become visible during an FDA inspection.

This detection gap signals one of two things: either the monitoring program lacks sufficient frequency or device placement in harborage-prone areas, or the program is being implemented on paper but not in practice. Both interpretations lead to the same FDA conclusion — the program is not effective.

2. The Harborage Condition

Cockroaches do not appear in food facilities without conditions that support their survival. FDA warning letters consistently document the structural and sanitation conditions that enabled the infestation: gaps behind equipment, voids in wall-floor junctions, areas of organic debris accumulation, utility chases without pest-proof seals, and harborage created by cardboard, clutter, and stored materials against walls.

Every one of these conditions should have been identified and corrected by the facility's pest management program. When FDA finds both cockroaches and harborage conditions in the same inspection, the citation is not just for the pest activity — it is for the failure of the preventive system.

3. The Corrective Action Record

In cockroach enforcement cases where FDA reviews prior inspection history, the most damaging finding is typically not the current infestation. It is evidence that prior cockroach findings — reported in PCO service reports — did not generate documented corrective actions at the facility level.

A PCO service report that notes "cockroach activity observed near floor drain in processing area — treated" followed by no facility-level corrective action record is not compliance. It is a paper trail that demonstrates the facility was aware of a problem and chose not to address its root cause.

The Biology That Makes Cockroaches a Special Compliance Risk

German cockroaches — the species most commonly found in food facilities — reproduce faster than any other cockroach species in the United States. A single gravid female can initiate an infestation of several hundred individuals within two to three months under favorable conditions. They aggregate in harborage areas, rarely travel far from food and moisture sources, and are primarily active at night — meaning daytime inspections rarely reveal the true population size.

Regulatory Framework: What 21 CFR 117.35 Requires

21 CFR 117.35(c) requires effective measures to exclude pests and protect food from contamination. For cockroaches, "effective measures" encompasses three distinct elements that FDA evaluates separately:

Exclusion: Structural integrity of the facility — all entry points sealed, utility penetrations protected, door sweeps functional, floor-wall junctions intact. This is a maintenance function, not a pest control function, and FDA holds the facility accountable for it regardless of what the PCO contract includes.

Monitoring: A detection program capable of identifying cockroach activity at early population stages — before the infestation becomes visible during a daytime inspection. This requires device placement in harborage-prone locations, not just perimeter placement, and inspection frequency appropriate for the facility's risk profile.

Response: When cockroach activity is detected, documented root cause investigation, corrective action with assigned ownership and due dates, harborage elimination, and verified closure. Treatment without documentation is not compliance.

21 CFR 117.20(b) requires that equipment and utensils be designed and maintained to prevent contamination of food. Cockroach harborage in equipment voids — a common finding — implicates this regulation in addition to 117.35.

PCI Analysis: The Full Compliance Picture

What GFSI Schemes Require Beyond FDA Baseline

BRCGS 4.14.4 requires that where cockroach activity is found, a full investigation is conducted to determine the extent of the infestation and a written remediation plan is developed. The plan must include timelines, responsible parties, and follow-up inspection dates. This is not optional — it is a documented requirement that auditors verify.

SQF 11.4.3 requires that pest control activities, including corrective actions arising from findings, be documented and records maintained. A PCO treatment record without a corresponding facility corrective action record is a gap that SQF auditors are specifically trained to identify.

FSSC 22000 PAS 220 10.5 requires that when pest evidence is found, the pest management PRP is reviewed for effectiveness. For cockroach findings, this means a documented review of monitoring frequency, device placement, harborage elimination protocols, and structural inspection procedures — not just a service call.

The Three Questions That Determine Your Exposure

When I assess a food facility's cockroach compliance exposure, I ask three questions that immediately reveal the state of the program:

1. When cockroach activity was last found at this facility, what facility-level corrective action was documented? If the answer is "the PCO treated it," that is not a corrective action. That is a service call. The facility-level corrective action addresses the harborage condition, the structural gap, the sanitation failure — the conditions that allowed the cockroach to establish.
2. What is the current harborage assessment status of this facility? Every food facility should have a documented harborage assessment — a systematic evaluation of all voids, gaps, utility chases, and clutter accumulation points — conducted at least annually, with corrective work orders generated and tracked to closure.
3. If a cockroach were found in your production area today, what would happen in the next 48 hours? The answer should be specific: who is notified, what investigation is conducted, what corrective actions are assigned, what documentation is created. If the answer is "we would call the pest control company," the program is reactive and the facility is exposed.

What Actual Compliance Requires

A cockroach-compliant food facility under 21 CFR 117.35 and GFSI standards maintains the following, continuously:

• A documented harborage assessment with all identified voids, gaps, and structural deficiencies tracked in a maintenance log with work order status and closure dates
• Monitoring device placement that includes harborage-prone locations — behind equipment, in utility chases, in wall-floor junctions — not just perimeter placement
• A documented escalation protocol: what triggers immediate notification, what triggers production hold consideration, what triggers third-party assessment
• Facility-level corrective action records for every cockroach finding — separate from PCO service records — that document root cause, assigned owner, due date, and verified closure
• Quarterly trend review that evaluates capture patterns by location, species, and time period to identify developing pressure before it becomes visible infestation

The Bottom Line

Cockroach findings in food facilities are not primarily a pest control problem. They are a program management problem. The infestation developed because conditions existed that the preventive program failed to identify and address. That program failure — not the cockroach — is what FDA is citing.

The path to defensibility is documented harborage elimination, detection programs that identify early activity, and facility-level corrective action records that demonstrate the program is actually working. Those three elements, consistently maintained, are what separates a facility that passes an FDA inspection from one that receives a warning letter.